SCM
ANGO icon

Suffolk Capital Management’s AngioDynamics ANGO Stock Holding History

Suffolk Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-187,756
Closed -$2.48M – 138
2015
Q3 		$2.48M Sell
187,756
-17,843
-9% -$269K 0.33% 86
2015
Q2 		$3.37M Buy
205,599
+20,859
+11% +$346K 0.4% 61
2015
Q1 		$3.29M Buy
184,740
+42,740
+30% +$794K 0.39% 70
2014
Q4 		$2.7M Buy
+142,000
New +$2.41M 0.33% 103

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Suffolk Capital Management's ANGO Position: Q4 2015 in Review

Suffolk Capital Management sold out of AngioDynamics (ANGO) in Q4 2015, closing a stake of 187,756 shares — an estimated $2.48M sold.

Suffolk Capital Management first reported a position in ANGO in Q4 2014 and held it in 4 quarters. The position peaked at $3.37M in Q2 2015. 121 funds tracked by Wall St. Rank hold ANGO as of Q4 2015.

  • Suffolk Capital Management reported no remaining AngioDynamics position as of Q4 2015 after selling out during the quarter.
  • Suffolk Capital Management sold 187,756 AngioDynamics shares in Q4 2015, an estimated $2.48M.
  • Suffolk Capital Management first reported a position in AngioDynamics in Q4 2014 and held it in 4 quarters.
  • Suffolk Capital Management's AngioDynamics position peaked at $3.37M in Q2 2015.
  • 121 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2015.

Based on Suffolk Capital Management's 13F filing for Q4 2015, filed 4 Feb 2016.